Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62,933,385
-
Total 13F shares
-
26,713,589
-
Share change
-
-628,053
-
Total reported value
-
$59,287,871
-
Price per share
-
$2.22
-
Number of holders
-
72
-
Value change
-
+$123,860
-
Number of buys
-
25
-
Number of sells
-
45
Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q3 2025
As of 30 Sep 2025,
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,713,589 shares.
The largest 10 holders included
Pfizer Inc, Laurion Capital Management LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Palo Alto Investors LP, MILLENNIUM MANAGEMENT LLC, STEMPOINT CAPITAL LP, BlackRock, Inc., and BANK OF AMERICA CORP /DE/.
This page lists
72
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.